AbbVie : ABBV

All AbbVie Articles

616 Articles

Alex Sirois | Jun 24, 2026 at 4:33 PM EDT

Why I Can’t Stop Buying This Unstoppable Dividend Juggernaut

I hit the buy button on AbbVie (NYSE:ABBV | ABBV Price Prediction) again last week, and I will hit it…

Drew Wood | Jun 24, 2026 at 11:38 AM EDT

The Dividend Portfolio That Starts Like A Honda And Ends Like A Ferrari

Most retirees shop for dividend portfolios the same way people shop for cars: they focus on what they get today.…

Alex Sirois | Jun 24, 2026 at 10:02 AM EDT

64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital

At 64, with $1.1 million in a Traditional IRA, tax-deferred cash flow is the point. With the 10-year Treasury at…

Trey Thoelcke | Jun 24, 2026 at 7:55 AM EDT

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching

Big Pharma's patent cliffs are forcing acquirers to hunt for revenue-producing biotech assets before rivals snap them up, and three…

Trey Thoelcke | Jun 23, 2026 at 7:55 AM EDT

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

Big pharma’s appetite for clinical-stage biotech is back. The pending acquisition of Apogee Therapeutics by AbbVie (NYSE: ABBV | ABBV…

Marc Guberti | Jun 21, 2026 at 4:17 PM EDT

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

The Health Care Select Sector SPDR ETF (NYSEARCA:XLV) is having a frustrating year. The fund sits at $149, down about…

Drew Wood | Jun 19, 2026 at 2:56 PM EDT

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

Ten thousand dollars a month works out to $120,000 a year, an income stream that exceeds the roughly $68,359 in…

Joel South | Jun 17, 2026 at 1:05 PM EDT

3 Dividend Stocks That Pay You More Every Single Year

Income investors keep coming back to the same playbook in choppy markets: own businesses that have raised their payouts every…

Drew Wood | Jun 17, 2026 at 8:59 AM EDT

How to Build $5,000 a Month in Dividend Income and Never Touch Your Principal

Five thousand dollars a month is the income many retirees are trying to generate from their investments. It is enough to…

Alex Sirois | Jun 16, 2026 at 4:42 PM EDT

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

For income investors weighing biopharma exposure, the dividend question on AbbVie (NYSE:ABBV | ABBV Price Prediction) just got a lot…

Vandita Jadeja | Jun 16, 2026 at 1:30 PM EDT

AbbVie Stock Will Hit $300 on This Date

AbbVie (NYSE:ABBV | ABBV Price Prediction) has quietly become one of healthcare’s most underrated growth stories. CEO Robert A. Michael…

Michael Williams | Jun 16, 2026 at 6:12 AM EDT

SCHD Now Concentrates 42 Percent of Your Money in Just 10 Stocks. Here Is Who Should Still Own It

Most Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) owners assume they are buying broad market diversification. The latest Schwab fact sheet…

Drew Wood | Jun 15, 2026 at 2:59 PM EDT

The Retiree Who Chose $65,000 Instead of $120,000 and Ended Up Richer

Two retirees walk into retirement with the same amount of money. One builds a portfolio that pays $120,000 a year…

John Seetoo | Jun 15, 2026 at 12:56 PM EDT

64 Years of Raises: How DGRO Finds Companies That Never Cut Dividends

The iShares Core Dividend Growth ETF (NYSEARCA:DGRO) was built for investors who want a paycheck that gets bigger every year,…

Joel South | Jun 13, 2026 at 9:30 AM EDT

3 Ridiculously Cheap Healthcare Stocks to Buy in June

Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care…

1 2 3 4 … 42

AbbVie : ABBV

All AbbVie Articles

Why I Can’t Stop Buying This Unstoppable Dividend Juggernaut

The Dividend Portfolio That Starts Like A Honda And Ends Like A Ferrari

64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

3 Dividend Stocks That Pay You More Every Single Year

How to Build $5,000 a Month in Dividend Income and Never Touch Your Principal

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

AbbVie Stock Will Hit $300 on This Date

SCHD Now Concentrates 42 Percent of Your Money in Just 10 Stocks. Here Is Who Should Still Own It

The Retiree Who Chose $65,000 Instead of $120,000 and Ended Up Richer

64 Years of Raises: How DGRO Finds Companies That Never Cut Dividends

3 Ridiculously Cheap Healthcare Stocks to Buy in June

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

SpaceX Just Erased $1 Trillion in Value. Here’s Why the Worst Could Be Yet to Come.

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

AbbVie : ABBV

All AbbVie Articles

Why I Can’t Stop Buying This Unstoppable Dividend Juggernaut

The Dividend Portfolio That Starts Like A Honda And Ends Like A Ferrari

64 Years Old With $1.1 Million in a Traditional IRA. Here’s Where I’m Allocating Capital

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

The Retirement Portfolio That Forks Over a $10,000 Check Every Month

3 Dividend Stocks That Pay You More Every Single Year

How to Build $5,000 a Month in Dividend Income and Never Touch Your Principal

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

AbbVie Stock Will Hit $300 on This Date

SCHD Now Concentrates 42 Percent of Your Money in Just 10 Stocks. Here Is Who Should Still Own It

The Retiree Who Chose $65,000 Instead of $120,000 and Ended Up Richer

64 Years of Raises: How DGRO Finds Companies That Never Cut Dividends

3 Ridiculously Cheap Healthcare Stocks to Buy in June

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

SpaceX Just Erased $1 Trillion in Value. Here’s Why the Worst Could Be Yet to Come.

Featured Reads

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account